KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Intangibles (2019 - 2025)

Historic Intangibles for Pacira BioSciences (PCRX) over the last 13 years, with Q3 2025 value amounting to $382.4 million.

  • Pacira BioSciences' Intangibles fell 1314.95% to $382.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $382.4 million, marking a year-over-year decrease of 1314.95%. This contributed to the annual value of $426.0 million for FY2024, which is 1185.45% down from last year.
  • Latest data reveals that Pacira BioSciences reported Intangibles of $382.4 million as of Q3 2025, which was down 1314.95% from $422.6 million recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Intangibles ranged from a high of $624.0 million in Q4 2021 and a low of $90.6 million during Q3 2021
  • Its 5-year average for Intangibles is $435.6 million, with a median of $468.9 million in 2024.
  • Per our database at Business Quant, Pacira BioSciences' Intangibles soared by 54645.83% in 2021 and then crashed by 1435.83% in 2023.
  • Over the past 5 years, Pacira BioSciences' Intangibles (Quarter) stood at $624.0 million in 2021, then decreased by 13.37% to $540.5 million in 2022, then dropped by 10.6% to $483.3 million in 2023, then decreased by 11.85% to $426.0 million in 2024, then dropped by 10.23% to $382.4 million in 2025.
  • Its Intangibles was $382.4 million in Q3 2025, compared to $422.6 million in Q2 2025 and $435.0 million in Q1 2025.